The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 05, 2018

Filed:

Jun. 17, 2014
Applicant:

Chu Sainte-justine, Montréal, CA;

Inventors:

Alain Moreau, Montréal, CA;

Marie-Yvonne Akoume Ndong, Montréal, CA;

Mohamed Elbakry, Montréal, CA;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/50 (2006.01); G01N 21/53 (2006.01); C07H 21/04 (2006.01); C07K 16/18 (2006.01); G01N 33/573 (2006.01); G01N 33/68 (2006.01); C12N 15/113 (2010.01); C12Q 1/68 (2018.01); C12Q 1/42 (2006.01); C12Q 1/48 (2006.01);
U.S. Cl.
CPC ...
G01N 33/573 (2013.01); C12N 15/1137 (2013.01); C12Q 1/42 (2013.01); C12Q 1/485 (2013.01); C12Q 1/6883 (2013.01); C12Y 207/01068 (2013.01); C12Y 301/03048 (2013.01); G01N 33/5047 (2013.01); G01N 33/5091 (2013.01); G01N 33/6893 (2013.01); C12N 2310/14 (2013.01); C12N 2320/30 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/912 (2013.01); G01N 2333/916 (2013.01); G01N 2333/91215 (2013.01); G01N 2800/10 (2013.01); G01N 2800/50 (2013.01); G01N 2800/56 (2013.01);
Abstract

Methods of stratifying a subject having or at risk for developing adolescent idiopathic scoliosis (AIS) into diagnostically or clinically useful subclasses are provided. The stratification is based on the subject's PTPμ expression and/or activity and/or PIPK1γ expression and/or activity. Also provided are methods of predicting the risk of developing a scoliosis also based on the subject's PTPμ expression and/or activity and/or PIPK1γ expression and/or activity; and methods of increasing GiPCR signaling in cells of a subject in need thereof comprising administering to the subject's cells an effective amount of an inhibitor of PIPK1γ tyrosine phosphorylation; an activator of PIPK1Y tyrosine dephosphorylation; and/or an inhibitor of PIPK1γ expression and/or activity.


Find Patent Forward Citations

Loading…